Literature DB >> 25580568

Anti-HLA antibody testing in hematology patients.

Jeremy Ryan A Peña1, Susan L Saidman.   

Abstract

Anti-human leukocyte antigens (HLA) antibodies can adversely impact the care of hematology patients. In particular, HLA antibody testing provides important information for optimal stem cell and platelet donor selection in the management of stem cell recipients and platelet refractory patients. Current testing methods for HLA antibodies are briefly reviewed, with particular emphasis on laboratory and clinical issues associated with solid-phase multiplex assays.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25580568      PMCID: PMC4401070          DOI: 10.1002/ajh.23935

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  23 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Frequency of HLA-DP-specific antibodies and a possible new cross-reacting group.

Authors:  Carly J Callender; Marcelo Fernandez-Vina; Mary S Leffell; Andrea A Zachary
Journal:  Hum Immunol       Date:  2011-11-23       Impact factor: 2.850

3.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

4.  Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads.

Authors:  Jianxin Qiu; Junchao Cai; Paul I Terasaki; Nadim El-Awar; Jar-How Lee
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

Review 5.  HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.

Authors:  Adriana Zeevi; Alin Girnita; Rene Duquesnoy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 6.  A mini-review on platelet refractoriness.

Authors:  Paolo Rebulla
Journal:  Haematologica       Date:  2005-02       Impact factor: 9.941

7.  Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity.

Authors:  A A Zachary; L Klingman; N Thorne; A R Smerglia; G A Teresi
Journal:  Transplantation       Date:  1995-09-15       Impact factor: 4.939

8.  Significance of the positive crossmatch test in kidney transplantation.

Authors:  R Patel; P I Terasaki
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

Review 9.  Evidence-based platelet transfusion guidelines.

Authors:  Sherrill J Slichter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

10.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

View more
  1 in total

Review 1.  The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

Authors:  Stefan O Ciurea; Kai Cao; Marcelo Fernandez-Vina; Piyanuch Kongtim; Monzr Al Malki; Ephraim Fuchs; Leo Luznik; Xiao-Jun Huang; Fabio Ciceri; Franco Locatelli; Franco Aversa; Luca Castagna; Andrea Bacigalupo; Massimo Martelli; Didier Blaise; Rupert Handgretinger; Denis-Claude Roy; Paul O'Donnell; Asad Bashey; Hillard M Lazarus; Karen Ballen; Bipin N Savani; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2018-01-15       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.